Title:
MUCOSAL VACCINE COMPOSITION
Document Type and Number:
Japanese Patent JP2015091792
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a mucosal vaccine composition which is be useful as a preventive or therapeutic agent of infectious diseases or cancer, can induce a systemic immune response and a mucosal immune response safely and effectively, and can be injected to oral mucosa, ophthalmic mucosa, ear mucosa, reproductive organ mucosa, pharyngeal mucosa, respiratory tract mucosa, tunica mucosa, pulmonary mucosa, gastric mucosa, intestinal mucosa, or rectal mucosa.SOLUTION: The invention provides a mucosal vaccine composition containing at least one kind of antigens, and, as an immunostimulant, a lipopolysaccharide derived from at least one kind of Gram negative bacteria, such as Serratia, Leclercia, Rahnella, Acidicaldus, Acidiphilium, Acidisphaera, Acidocella, Acidomonas, Asaia, Belnapia, Craurococcus, Gluconacetobacter, Gluconobacter, Kozakia, Leahibacter, Muricoccus, or a salt thereof.
Inventors:
FUKASAKA MASAHIRO
HORI MITSUHIKO
OKUBO KATSUYUKI
ASARI DAISUKE
OKAZAKI ARIMICHI
KIYOTOO HIDEJI
MATSUSHITA KYOHEI
HORI MITSUHIKO
OKUBO KATSUYUKI
ASARI DAISUKE
OKAZAKI ARIMICHI
KIYOTOO HIDEJI
MATSUSHITA KYOHEI
Application Number:
JP2014204022A
Publication Date:
May 14, 2015
Filing Date:
October 02, 2014
Export Citation:
Assignee:
NITTO DENKO CORP
International Classes:
A61K39/39; A61K9/06; A61K9/08; A61K9/20; A61K9/72; A61K39/00; A61P31/00; A61P35/00; A61P37/04
Domestic Patent References:
| JP2009242367A | 2009-10-22 | |||
| JP2007505836A | 2007-03-15 | |||
| JP4043533B2 | 2008-02-06 | |||
| JP5650780B2 | 2015-01-07 | |||
| JP2013527218A | 2013-06-27 |
Other References:
日本免疫学会総会・学術集会記録, 2012, VOL.41, P.89(1K-W20-11-P), JPN6018020960, ISSN: 0003812211
ENDOCR METAB IMMUN DISODERS-DRUG TARGETS., 2012, VOL.12, P.221-235, JPN6018020955, ISSN: 0003812212
日本獣医学会学術集会講演要旨集, 2009, VOL.147, P.256(EP-6), JPN6018020956, ISSN: 0003812213
IMMUNOL LETT., 2006, VOL.107, P.131-139, JPN6018020958, ISSN: 0003812215
VETER IMMUNOL IMMUNOPATHOL., 2009, VOL.131, P.285-289, JPN6018020959, ISSN: 0003812216
VACCINE, 2013 MAR, VOL.31 NO.11, P.1480-1489, JPN6018020957, ISSN: 0003812214
ENDOCR METAB IMMUN DISODERS-DRUG TARGETS., 2012, VOL.12, P.221-235, JPN6018020955, ISSN: 0003812212
日本獣医学会学術集会講演要旨集, 2009, VOL.147, P.256(EP-6), JPN6018020956, ISSN: 0003812213
IMMUNOL LETT., 2006, VOL.107, P.131-139, JPN6018020958, ISSN: 0003812215
VETER IMMUNOL IMMUNOPATHOL., 2009, VOL.131, P.285-289, JPN6018020959, ISSN: 0003812216
VACCINE, 2013 MAR, VOL.31 NO.11, P.1480-1489, JPN6018020957, ISSN: 0003812214
Attorney, Agent or Firm:
Atomi International Patent Office
Previous Patent: INFLUENZA VACCINE DRY FORMULATION, AND METHOD FOR PRODUCING INFLUENZA VACCINE DRY FORMULATION
Next Patent: MUCOSAL VACCINE COMPOSITION
Next Patent: MUCOSAL VACCINE COMPOSITION